.jpg)
Practice Leader - US Retrospective Research
IQVIA
As Senior Principal, Health Economics and Outcomes Research at IQVIA, Mitchell DeKoven leads teams in a variety of health economics and outcomes research projects, including value development plans, retrospective database studies, and observational surveys. He is also instrumental in new business development efforts.
Mr. DeKoven was an associate director of reimbursement and market access at ValueMedics Research LLC, which IQVIA acquired in March 2007. Prior to joining ValueMedics, he was manager of reimbursement services at United BioSource Corporation’s Center for Pricing & Reimbursement. Before that, was a consultant with CHPS Consulting, now Navigant Consulting.
Previous to his experience at CHPS, Mr. DeKoven was the program manager of the Center for Cancer and Blood Disorders at Children’s National Medical Center in Washington, DC, a position he held after completing a two-year administrative fellowship with the Johns Hopkins Health System.
Mr. DeKoven is past president of the board of directors of the Lupus Foundation of America’s Greater Washington Chapter, sits on the editorial advisory boards of Biotechnology Healthcare, the Journal of Commercial Biotechnology, the Journal of Comparative Effectiveness Research, Medical Device and Diagnostic Industry, the American Journal of Pharmacy Benefits, and Expert Review of Pharmacoeconomics and Outcomes Research, and is a peer reviewer for Formulary, the Journal of Pharmaceutical Marketing and Management, the Journal of Medical Economics, and the American Journal of Managed Care. He has also published several articles in leading health care journals.
Mr. DeKoven earned his M.H.S.A. from the University of Michigan School of Public Health and his B.A. in Spanish from Washington University in St. Louis.